Integer Quarterly Cash Flow Statement
NYSE: ITGRHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Integer free cash flow
In the quarter ended Jul 3, 2026, Integer generated $59.7 million of operating cash flow and spent $22.7 million on capital expenditures. That left free cash flow of $37.0 million, a free-cash-flow margin of 8.0% of revenue. Free cash flow was up 49.0% from the prior year's $24.9 million.
Summary generated from market data by MetaCap's automated system. Methodology
Integer cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-07-03 | Q1 20262026-04-03 | Q4 20252025-12-31 | Q3 20252025-09-26 | Q2 20252025-06-27 | Q1 20252025-03-28 | Q4 20242024-12-31 | Q3 20242024-09-27 | Q2 20242024-06-28 | Q1 20242024-03-29 | Q4 20232023-12-31 | Q3 20232023-09-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 23.61M | 16.51M | 48.61M | 39.68M | 37.01M | -22.49M | 32.70M | 35.44M | 31.25M | 20.51M | 26.36M | 27.26M |
| Net Income growth (YoY) | -36.22% | — | +48.63% | +11.96% | +18.44% | -209.65% | +24.08% | +30.02% | +30.35% | +56.97% | +45.48% | +69.75% |
| Depreciation & Amortization | 34.54M | 35.01M | 35.51M | 33.04M | 32.29M | 29.83M | 28.93M | 28.69M | 27.23M | 26.18M | 25.73M | 24.55M |
| Stock-Based Compensation | 5.38M | 6.66M | 5.76M | 4.93M | 5.66M | 6.88M | 6.04M | 6.12M | 5.77M | 6.85M | 6.18M | 5.50M |
| Change in Working Capital | 644.00K | -37.85M | -30.20M | -10.89M | -26.82M | -40.38M | 970.00K | -4.36M | -3.43M | -30.17M | -10.37M | 6.72M |
| Operating Cash Flow | 59.73M | 24.70M | 55.41M | 65.59M | 43.86M | 31.28M | 63.23M | 71.50M | 47.23M | 23.24M | 55.59M | 62.29M |
| Capital Expenditures | -22.69M | -23.96M | -27.48M | -19.34M | -19.00M | -25.22M | -19.09M | -26.02M | -31.18M | -29.07M | -37.05M | -25.47M |
| Investing Cash Flow | -22.68M | -37.90M | -35.47M | -20.27M | -17.83M | -197.17M | 29.62M | -26.23M | -30.60M | -168.20M | -80.58M | -25.42M |
| Share Repurchases | 0 | -50.00M | — | — | 0 | 0 | — | — | — | — | — | — |
| Debt Issued | 0 | 0 | 0 | 0 | 0 | 977.50M | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Repaid | 0 | 0 | -10.01M | -4.00K | -44.01M | -613.68M | -4.00K | -2.00K | 0 | 0 | 0 | -17.50M |
| Financing Cash Flow | -23.59M | 3.83M | -61.72M | -10.71M | -35.59M | 151.58M | -82.30M | -43.14M | -24.53M | 163.29M | 17.52M | -43.13M |
| Net Change in Cash | 13.26M | -9.05M | -41.78M | 35.81M | -8.58M | -14.83M | 10.97M | 1.44M | -8.02M | 18.48M | -8.47M | -6.47M |
| Free Cash Flow | 37.04M | 737.00K | 27.94M | 46.26M | 24.86M | 6.06M | 44.14M | 45.48M | 16.05M | -5.83M | 18.53M | 36.82M |
This table shows 12 quarterly periods of Integer's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ITGR's reporting calendar. What is a cash flow statement?